文献詳細
今月の臨床 婦人科がんの予防戦略と早期診断
卵巣がん
文献概要
●家族性卵巣がんは,家族性卵巣がん(狭義),家族性乳がん・卵巣がん症候群,遺伝性非腺腫性大腸がん家系に分類される.
●家族性卵巣がんの原因遺伝子としてBRCA1 , BRCA2 ,遺伝性非腺腫性大腸がんの原因遺伝子としてミスマッチ遺伝子が同定されている.
●BRCA1/2 carrierでは卵巣がん罹患の生涯リスクが16~30%(一般は約1.8%)と異常に高率で,卵巣がんの約10%はBRCA1 ,BRCA2 carrierに発症している.
●日本人の家族性卵巣がんに対する適切・具体的な取扱いに関するガイドラインの作成も含め,大いに議論を深め検討する時期である.
●家族性卵巣がんの原因遺伝子として
●
●日本人の家族性卵巣がんに対する適切・具体的な取扱いに関するガイドラインの作成も含め,大いに議論を深め検討する時期である.
参考文献
1) Lynch HT, Krush AJ : Cancer family “G” revisited 1895─1970. Cancer 27 : 1505─1519, 1971
2) Li FP, Fraumeni JF Jr : Soft tissue sarcomas, breast cancer and other neoplasma : A familial syndrome? Ann Intern Med 71 : 745─775, 1969
3) Markin D, Li FP, Strong LC, et al : Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 : 1209, 1990
4) Miki Y, Swenson J, Shattuck-Eidens D, et al : A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 : 66─71, 1994
5) Matsushima M, Kobayashi K, Emi M, et al : Mutational analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients : four germ line mutations, but no evidence of somatic mutation. Hum Mol Genet 4 : 1953─1956, 1995
6) Aida H, Takakuwa K, Nagata H, et al : Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1. Clin Cancer Res 4 : 235─240, 1998
7) Sekine M, Nagata H, Tsuji S, et al : Japanese Familial Ovarian Cancer Study Group : Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families : two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7 : 3144─3150, 2001
8) Goldgar D, Stratton MR : Inherited Tumour Syndromes. In “WHO classification of tumours. Pathology&Genetics. Tumours of the breast and female genital organs”. Ed. by Tavassoli FA, Devilee P. IARC press, pp336─363, 2003
9) Kashima K, Oite T, Aoki Y, et al : Screening of BRCA1 mutation using immunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers. Jpn J Cancer Res 91 : 399─409, 2000
10) Aoki Y, Tanaka K : Role of Immunohistochemical Expression of BRCA1 in Ovarian Carcinoma. HANDBOOKS of IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION OF HUMAN CARCINOMAS. Molecular genetics, Gastrointestinal carcinoma, and ovarian carcinoma. Ed. MA Hayat, Elsevier Academic Press, Burlington, MA, USA. pp339─346, 2006
11) Rebbeck TR, Kauff ND, Domchek SM : Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101 : 80─87, 2009
12) Vasen HF, Watson P, Mecklin JP, et al : IGC-HNPCC : New clinical criteria for hereditary nonpolyposis colorectal cancer(HNPCC, Lynch syndrome) proposed by the International collaborative group on HNPCC. Gastroenterology 116 : 1453─1456, 1999
13) http://www.tri-kobe.org/nccn/guideline/gynecological/english/genetic_familial.pdf
14) http://www.falco-genetics.com/
15) http://jsft.umin.jp/guideline.html
16) http://jams.med.or.jp/guideline/genetics-diagnosis.pdf
17) American College of Obstetricians and Gynecologists ; ACOG Committee on Practice Bulletins--Gynecology ; ACOG Committee on Genetics ; Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103 : Hereditary breast and ovarian cancer syndrome. Obstet Gynecol 113 : 957─966, 2009
18) Clinical Guideline, Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility : Systematic Evidence Review for the U.S. Preventive Services Task Force. Ann Int Med 143 : 362─379, 2005
19) Robson ME, Storm CD, Wollins DS, et al : American Society of Clinical Oncology Policy Statement Update : Genetic Testing for Cancer Susceptibility. J Clin Oncol 28 : 893─901, 2010
20) American Society of Clinical Oncology Policy Statement Update : Genetic Testing for Cancer Susceptibility. J Clin Oncol 21 : 2397─2406, 2003
21) 日本乳癌学会 編 : 科学的根拠に基づく乳癌診療ガイドライン 2疫学・診断編 2011年版.金原出版,2011
掲載誌情報